| Literature DB >> 29109870 |
Claudine A Blum1, Daniel Schneeberger1, Matthias Lang1, Janko Rakic1,2, Marc Philippe Michot1, Beat Müller1.
Abstract
INTRODUCTION: Diagnosis of adrenal crisis and panhypopituitarism in patients with septic shock is difficult but crucial for outcome. CASE: A 66-year-old woman with metastasized breast cancer presented to the ED with respiratory insufficiency and septic shock after a 2-day history of the flu. After transfer to the ICU, corticosteroids were started in addition to antibiotics, as the patient was vasopressor-nonresponsive. Diabetes insipidus was diagnosed due to polyuria and treated with 4 mg desmopressin. Thereafter, norepinephrine could be tapered rapidly. On day 2, basal cortisol was 136 nmol/L with an increase to 579 nmol/L in low-dose cosyntropin testing. Polyuria had not developed again. Therefore, corticosteroids were stopped. On day 3, the patient developed again nausea, vomiting, and polyuria. Adrenal crisis and diabetes insipidus were postulated. Corticosteroids and desmopressin were restarted. Further testing confirmed panhypopituitarism. MRI showed a new sellar metastasis. After 2 weeks, stimulated cortisol in cosyntropin testing reached only 219 nmol/l, confirming adrenal insufficiency. DISCUSSION: The time course showed that the adrenal glands took 2 weeks to atrophy after loss of pituitary ACTH secretion. Therefore, a misleading result of the cosyntropin test in the initial phase with low basal cortisol and allegedly normal response to exogenous ACTH may be seen. Cosyntropin testing in the critically ill should be interpreted with caution and in the corresponding clinical setting.Entities:
Year: 2017 PMID: 29109870 PMCID: PMC5646303 DOI: 10.1155/2017/7931438
Source DB: PubMed Journal: Case Rep Crit Care ISSN: 2090-6420
Laboratory values.
| Variable | Reference range, adults | One week before admission | Day 1, 10 a.m. | Day 1, 10 p.m. | Day 2 | Day 3 | Day 4 | Day 8 | Day 15 | Day 32 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hematocrit (%) | 36.0–45.0 | 0.423 | 0.433 | 0.353 | 0.372 | 0.297 | 0.384 | |||
| Hemoglobin (g/l) | 120–155 g/l | 140 | 137 | 107 | 118 | 97 | 118 | |||
| White cell count (per mm3) | 4000–10000 | 5700 | 9500 | 9400 | 6400 | 7000 | 7390 | |||
| Thrombocytes (G/l) | 140–400 | 234 | 287 | 277 | 292 | 243 | 306 | |||
| Sodium (mmol/l) | 136–146 | 148 | 139 | 153 | 147 | 147 | 151 | 143 | 144 | |
| Potassium (mmol/l) | 3.6–5.0 | 3.6 | 3.9 | 3.8 | 4.3 | 4.2 | 4.3 | 4.3 | ||
| Osmolality (mosmol/kg) | 280–300 | 298 | 320 | 310 | 298 | |||||
| Urine osmolality (mosmol/kg) | 100–1200 | 148 | 274 | 146 | 271 | |||||
| Urea (mmol/l) | 2–7 | 8.1 | 4.6 | 4.9 | 5.7 | 7 | ||||
| Creatinine (umol/l) | 53–94 | 61 | 170 | 120 | 91 | 83 | 90 | 55 | ||
| Procalcitonin (ug/l) | <0.5 | 0.18 | 0.47 | 3.88 | ||||||
| C-reactive protein mg/l | <3.0 | 15.8 | 79.2 | 71.3 | 100 | 47.3 | ||||
| Copeptin (pmol/l) | <31 | 4.8 | 2.3 | |||||||
| Vasopressin (ADH) (pmol/l) | 1.0–4.2 | <0.90 | ||||||||
| TSH (mU/l) | 0.4–4.0 | 0.14 | 0.05 | 0.07 | 0.1 | |||||
| T3 (nmol/l) | 0.90–2.60 | 2.05 | 0.91 | |||||||
| fT4 (nmol/l) | 9.9–19.3 | 10.1 | 8.71 | |||||||
| HGH (ug/l) | <7 | 0.23 | ||||||||
| IGF1 (ug/l) | 59–195 | 64.7 | 105 | |||||||
| FSH (U/l) | 19–140 | 1.08 | 1.77 | |||||||
| Prolactin (ug/l) | 2.2–28 | 73.6 | 94.3 | |||||||
| Morning cortisol (nmol/l) | 140–700 | 258 | ||||||||
| Cosyntropin test (low dose) | ||||||||||
| Cortisol 0′ (nmol/l) | 136 | 292 | 122 | 67 | ||||||
| Cortisol 30′ (nmol/l) | >500 | 579 | 497 | 356 | 219 |
Figure 1Inhomogeneity of the pituitary indicative of local metastases. Sagittal T1-weighted MRI (a) and coronal T2-weighted MRI (b) of the pituitary showed signal increase suggesting hemorrhage (arrows). Coronal T1-weighted MRI (c) with contrast shows inhomogeneous enhancement of pituitary with metastasis.